NEWS

CONNECT WITH US

	Become a fan on Facebook
	Add us on Google Plus
	Follow us on Twitter
	Join us on LinkedIn
	Sign up for our Newsletters
	Subscribe to our RSS Feed

Brain Tumors

Erlotinib Plus WBRT Effective for NSCLC Brain Metastases

RESEARCH REPORT
Dave Levitan
The combination of whole-brain radiation therapy and the EGFR inhibitor erlotinib showed a promising response rate and was well tolerated in a new phase II trial of patients with brain metastases from non-small-cell lung cancer.
Insights and Therapies for Breast Cancer Brain Mets

REVIEW ARTICLE
Elgene Lim, Nancy U. Lin; ONCOLOGY Vol. 26 No. 7
This review will focus on the breast cancer subtypes with the highest incidence of breast cancer brain metastases and will characterize differences in the clinical behavior of brain metastases that arise from these different subtypes.
• Tumor Biology Trumps Anatomy in Breast Cancer Brain Metastases
• Brain Metastasis in Breast Cancer: Last Barrier to the Cure?

REVIEW ARTICLES

Innovation in the Management of Brain Metastases
Ravi D. Rao, MD, Paul D. Brown, MD, Jan C. Buckner, MD , April 1, 2007

Therapy of patients with brain metastases requires a combination of measures to achieve local control at the site of metastasis and to reduce the subsequent risk of recurrences elsewhere in the brain. In the current review, we discuss recent developments in the management of patients with brain metastases.
• Management of Brain Metastases: Neurosurgical Considerations
• Brain Metastases and the Need for a Multispecialist Approach

Recent Advances in the Treatment of Pediatric Brain Tumors
Sri Gururangan, MRCP (UK)¹Henry S. Friedman, MD² , November 1, 2004

Central nervous system (CNS) cancers are the second most frequent malignancy in childhood. In recent years, significant advances in surgery, radiotherapy, and chemotherapy have improved survival in children with these tumors. However, a significant proportion of patients with CNS tumors suffer progressive disease despite such treatment.
• Commentary (Olson)
• Commentary (Asgharzadeh/Finlay)

Brain Metastases in Small Cell Lung Cancer
Aimee L. Quan, MD¹, Gregory M.M. Videtic, MD², John H. Suh, MD³ , July 1, 2004

The purpose of this paper is to provide an overview of the clinical presentation, diagnosis, and treatment of brain metastases in patients with SCLC, with a focus on current trends and developments in the treatment of this disease.

MORE ON BRAIN TUMORS

November 26, 2012

MRI Predicts Survival from Bevacizumab Treatment for Glioblastoma

Changes in tumor enhancement detected by post-gadolinium (Gd) T1-weighted MRI are highly predictive of which patients with recurrent glioblastoma... More »

April 23, 2012

Ganglioglioma

April 10, 2012

Frequent Dental X-Rays Linked to Increased Brain Tumor Risk

Ionizing radiation from frequent dental X-rays may increase the risk of meningioma, researchers found. More »

February 8, 2012

Podcast: Using MRI in the Operating Room

January 27, 2012

New MRI Technique Helps Diagnose Gliomas

A new magnetic resonance spectroscopy technique provides a definitive diagnosis of brain cancer based on imaging of a protein associated with a... More »

Showing 1 - 5 of 110 results.

Page of 22

First Previous Next Last

MEDLINE

Label-free impedimetric immunosensor for ultrasensitive detection of cancer marker Murine double minute 2 in brain tissue.

pubmed.gov - 1/14/13

A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life

pubmed.gov - 12/31/12

Semiquantitative analysis using thallium-201 SPECT for differential diagnosis between tumor recurrence and radiation necrosis after gamma knife surgery for malignant brain tumors.

pubmed.gov - 12/31/12

The role of cancer stem cells and miRNAs in defining the complexities of brain metastasis.

pubmed.gov - 12/31/12

Immunologic privilege in the central nervous system and the blood-brain barrier.

pubmed.gov - 12/31/12

CLINICAL TRIALS

Aberrant miRNA expression in brain tumors: a subject attracting an increasing amount of attention